SYNH - Syneos Health Inc - Class A
Close
42.98
0.010 0.023%
Share volume: 0
Last Updated: Wed 27 Sep 2023 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$42.97
0.01
0.02%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-04-29 | 2022-08-02 | 2022-11-04 | 2023-02-16 | 2023-05-10 | 2023-08-09 | |
| Assets | |||||||
| Total Assets | 8.304 B | 8.217 B | 8.198 B | 8.199 B | 8.099 B | 8.075 B | |
| Current Assets | 1.876 B | 1.882 B | 1.963 B | 1.944 B | 1.946 B | 1.952 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 160.792 M | 168.932 M | 145.645 M | 186.770 M | 184.320 M | 169.947 M | |
| Short Term Investments | 160.792 M | 168.932 M | 145.645 M | 186.770 M | 184.320 M | 169.947 M | |
| Total Receivables | 1.596 B | 1.607 B | 1.647 B | 1.645 B | 1.651 B | 1.700 B | |
| Current Cash | 119.151 M | 105.988 M | 170.100 M | 112.004 M | 111.055 M | 82.276 M | |
| Total Non-current Assets | 6.428 B | 6.335 B | 6.235 B | 6.255 B | 6.152 B | 6.124 B | |
| Property Plant Equipment | 240.015 M | 254.891 M | 255.749 M | 264.295 M | 245.672 M | 236.697 M | |
| Other Assets | 199.835 M | 203.723 M | 201.385 M | 189.135 M | 195.783 M | 213.316 M | |
| Intangible Assets | 808.931 M | 759.436 M | 710.637 M | 680.863 M | 644.843 M | 608.433 M | |
| Goodwill | 4.943 B | 4.898 B | 4.850 B | 4.898 B | 4.907 B | 4.912 B | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 8.304 B | 8.217 B | 8.198 B | 8.199 B | 8.099 B | 8.075 B | |
| Total liabilities | 5.002 B | 4.888 B | 4.844 B | 4.704 B | 4.644 B | 4.582 B | |
| Total current liabilities | 1.722 B | 1.707 B | 1.723 B | 1.725 B | 1.688 B | 1.627 B | |
| Accounts Payable | 108.315 M | 99.319 M | 118.952 M | 118.621 M | 145.967 M | 137.017 M | |
| Other liabilities | 59.423 M | 54.415 M | 54.996 M | 56.513 M | 65.947 M | 58.183 M | |
| Current long term debt | 21.998 M | 23.678 M | 25.053 M | 24.011 M | 21.743 M | 28.772 M | |
| Long term debt | 2.946 B | 2.861 B | 2.803 B | 2.655 B | 2.650 B | 2.677 B | |
| Other liabilities | 59.423 M | 54.415 M | 54.996 M | 56.513 M | 65.947 M | 58.183 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.302 B | 3.329 B | 3.354 B | 3.495 B | 3.454 B | 3.494 B | |
| Common stock | 103.665 M | 102.596 M | 102.731 M | 102.904 M | 103.326 M | 103.679 M | |
| Retained earnings | -52.627 M | 25.117 M | 112.166 M | 167.694 M | 95.545 M | 96.338 M |